The Global CME Impact Award, recognizes excellence, influence, and achievements by organizations and individuals implementing impactful and innovative Continuing Medical Education (CME)/Continuing Education (CE) activities that transform healthcare for the greater good.
Each year, a panel of six to eight CME / CE professionals serve on the judging committee to score each entry in 6 main categories. The judging categories are as follows:
-
Innovation: Explain how your program was innovative. What was novel in the design, development, delivery of your project/program. Please explain the unique approach you designed and /or deployed.
-
Adult teaching methodologies: Describe the adult learning and teaching methods used for your project/program, and illustrate the learner experience.
-
Collaborative: Did your project/program engage other stakeholders in the design and development? Did you use collaborative teaching methods? If so, summarize the collaborative model, roles of each organization, or methods used and why they were important to the project.
-
Patient Engagement: Did your project/program focus on maximizing patient engagement in shared decision-making, self-management, provider-patient communication, etc? If yes, describe the model and impact patient engagement had in your project/program.
-
Educational Impact: Summarize the educational impact your project/program had on the learners. Did your project affect organizational, team, provider knowledge, skills or behavior changes? What were the metrics, desired, outcomes, did you meet or exceed your program objectives?. Preference will be given to proposals that clearly outline an evidence-based approach to designing CME that is more likely to improve physician performance and patient health outcomes using Moore et al., CME Framework or other models that measure change in knowledge, skills, behavior and performance.
-
Sustainability: Tell us how your project/program is sustainable for the learner.
To learn more and to inquire about 2020 Awards visit: https://www.globalcmeaward.com or email John McCormick at info@globalcmeaward.com.
2018 Award Results
Congratulations to Med Learning Group!
2016 Award Results
Global Education Group and the Global Alliance for Medical Education announced Med Learning Group received the 2018 Global CME Impact Award for "The CARES Initiative: New Therapeutic Options and Expert Guidance for the Comprehensive, Patient-Centered Management of T2DM."
Presented in May at the GAME Annual Meeting in New Jersey, the Global CME Impact Award recognizes excellence, influence, and achievements by organizations and individuals implementing impactful and innovative Continuing Medical Education (CME)/Continuing Education (CE) activities that transform healthcare for the greater good.
Med Learning Group was one of five finalists selected from 22 applications representing six countries and 15 therapeutic areas.
About The CARES Initiative
The CARES diabetes initiative provides valuable information about the pathophysiology and long-term management of type 2 diabetes by employing both live and online CME offerings for healthcare providers. Med Learning Group’s goal is to assist healthcare providers by providing them with high-quality, unbiased information about current and emerging treatments and management techniques that address the chronic, progressive nature of the disease. By gathering together important information about American Diabetes Association standards of care, evidence-based strategies for effective, long-term antihyperglycemic management, and data on existing and investigational therapies for type 2 diabetes, Med Learning Group hopes to improve patient care and the quality of life for the millions of Americans living with diabetes today.
A panel of six CME / CE professionals served on the judging committee to score each entry in 6 main categories:
-
Innovation
-
Adult Teaching Methodologies
-
Collaboration
-
Patient Engagement
-
Educational Impact
-
Sustainability
The 2018 judging committee included: Celine Carrera, The European Society of Cardiology; Sherlyn Celone, Integrated Learning Partners; Lisa Sullivan, In Vivo Academy; Audrie Tornow, Paradigm Medical Communications; Laura Muttini, Educational Health Strategies; Suzanne Murray, AXDEV Group.
After a thorough judging and review process, the judging committee determined the final order of the finalists, shown below. We encourage you to follow the links provided to learn more about each of the finalists and their CME program. Each link includes the abstract that was submitted to the award committee, and you will be able to learn more about each CME program and the outcomes and overall impact that each program achieved.
2018 Global CME Impact Award- Finalists
The other finalists for the award included:
-
National Jewish Health - Collaborative Approach to Improve the Cardiovascular Health of Patients With Rheumatoid Arthritis
-
The Academy for Continued Healthcare Learning - The Evolution of Therapies for NSCLC: Navigating New Therapies & Counseling Patients In Clinical Decisions
-
Haymarket Medical Education - Adopting a Patient-Centered Approach to Improve Outcomes and Quality of Life: The OAB Learning Center
Congratulations to AXDEV Group
Global Education Group and Global Alliance for Medical Education are pleased to announce that AXDEV Group, The European Performance Improvement in Diabetes Demonstration Project (EPIDD), received the inaugural Global CME Impact Award.
Suzanne Murray, AXDEV Group, receiving the 2016 Global CME Impact Award Presented on January 27th, 2017, at the 42nd Annual Alliance conference in San Francisco, CA, the Global CME Impact Award recognizes excellence, influence, and achievements by organizations and individuals implementing impactful and innovative Continuing Medical Education (CME)/Continuing Education (CE) activities that transform healthcare for the greater good.
AXDEV Group’s EPIDD was one of four finalists selected from 22 applications representing six countries and 15 therapeutic areas. The countries included the United States, Canada, Austria, Qatar, Australia, and India. Therapeutic areas included Ophthalmology, Primary Care, Breast Cancer, Pain, Atrial Fibrillation, Alzheimer’s, IBD, Social Media in CME, Psychosis, COPD, OAB, Diabetes, Hepatology, Migraine, and Obesity.
About EPIDD
The EPIDD was a four-phase performance improvement program intended to measurably impact the performance of primary care clinical professional teams in the treatment and care of patients with diabetes. The EPIDD was performed in Santander (Cantabria, Spain) in partnership with local public health authorities and Eli Lilly. Healthcare professionals (physicians and nurses) from primary care centers in the urban/semi-urban area of Santander participated in the project. Participants reported improvements in clinical inertia, communication with patients, management of complications (diabetes foot, hypoglycemia) and complex insulin management and initiation cases.
2016 Global CME Impact Award- Finalists
The other finalists for the award included: